Stock & Company Details
Abbvie Inc $ABBV
Price:
N/A
N/A
1.8B
$481B
52 Week High:
N/A
10 Day Average Volume:
N/A
76.54
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ABBV technical indicators
Latest Abbvie Inc (ABBV) indicator readings as of 2026-10-09.
ABBV's 14-day RSI is 71.2, in overbought territory. At $276.47 it is trading 18.8% above its 200-day moving average of $232.63, and above its 50-day average of $258.89. Price sits above the upper Bollinger Band ($257.58 to $273.03). ADX reads 22.3, sitting between trending and range-bound.
ABBV backtested strategy results
How 4 rule-based strategies performed on Abbvie Inc (ABBV) over recent history, last backtested 2026-10-07. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +114.9% | 100% | 10 | -10.4% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +51.1% | 41% | 29 | -20.9% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | +48.9% | 43% | 28 | -21.8% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +4.0% | 74% | 23 | -23.9% |
Overview
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Finance Bot
Ask your questions
Start by typing a question below.
